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Abstract
Psychotropic medications should be used with extreme caution in older adults residing in longterm care facilities. Delirium and altered mental status are associated with multiple complex
underlying medical conditions and can be difficult to recognize, particularly among the elderly
residing in long-term care facilities. The use of the California Department of Public Health
(CDPH) Skilled Nursing Facility (SNF) Antipsychotic Toolkit allows for ethical and evidencebased care of the elderly within the regulations and best practice for use of antipsychotics. This
Doctor of Nursing Practice quality improvement project is designed to provide a toolkit for
practitioners of behavioral modification measures and an introduction to the CDPH SNF
Antipsychotic Toolkit for use among local nursing homes in the San Francisco Bay Area of
California. The clinical relevance is for geriatric nurses and health care providers to recognize
value of utilizing the CDPH SNF Antipsychotic Toolkit before prescribing and administering
antipsychotic medications to the older adult population in nursing homes. The toolkit emphasizes
the importance of recognizing possible adverse effects and the importance of identifying
delirium and interventions.
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Section II: Introduction
Problem Description
According to the National Center for Health Statistics, 47.8% of patients residing in longterm care (LTC) facilities have been diagnosed with Alzheimer’s disease or other dementia
(Centers for Disease Control and Prevention [CDC], 2016). Individuals with dementia are at
great risk of developing delirium secondary to age-related changes. As a result, the pain process
is altered, they are less able to ask for help with basic needs, and they are less able to
communicate that they are in pain or feeling unwell (Featherstone, Hopton, & Siddigi, 2010). It
is important that health care workers, nursing, and support staff understand how to prevent,
recognize, and manage delirium, because delirium can be mistaken as dementia.
Delirium and altered mental status are associated with multiple complex underlying
medical conditions that can be difficult to recognize, particularly among elderly residing in LTC
facilities. The American Psychiatric Association’s Diagnostic and Statistical Manual, 5th edition
(DSM-V) lists five key features that manifest delirium: (a) disturbance in attention and
awareness; (b) the disturbance develops over a short period of time, represents a change from
baseline; (c) disturbance in cognition (memory deficit, disorientation, or perception); (d) the
disturbances are not better explained by preexisting disorder or established as neurocognitive
disorder; and (e) there is evidence from the history, physical examination, or laboratory findings
that the disturbance is caused by a medical condition, substance intoxication or withdrawal, or
medication side effect (in Francis & Young, 2014). Although a number of criteria exist for
dementia, the DSM-V criteria for dementia include the following: (a) significant cognitive
impairment in at least one of the cognitive domains (learning and memory, language, executive
function, complex attention, perceptual-motor function, and social cognition); (b) impairment
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represents a significant decline from previous level of functioning; and (c) cognitive deficits
interfere with independence in everyday activities (Larson, 2016).
Failure to assume responsibility of nursing home management, licensed nurses, and most
especially, nurse practitioners and medical doctors who are prescribing the antipsychotic
medications, can lead to very serious consequences and even death in elderly patients. Progress
has been shown with the Centers for Medicare and Medicaid Services’ (CMS) strategies to
reduce antipsychotic drug use in nursing home residents with dementia. Continuous monitoring
and consistent enforcement are needed to ensure decline in unnecessary use of antipsychotics
and psychoactive medications in nursing homes (Lucas & Bowblish, 2017).
Ferguson, Montgomery, Mossey and Duncan (2018), in a summarized evidence of nonpharmacological nursing interventions for delirium prevention in LTC facilities, concluded that
there is limited evidence on nursing interventions to prevent delirium in LTC facilities. Ferguson
et al. reported (a) an increased need for education of delirium risk factors, (b) the importance of
knowledge of the resident as an individual, and (c) potentially modifiable risk factors associated
with increased delirium severity, such as dehydration, disorientation, absence of assisted device,
absence of family member, environmental management, constipation prevention, physician/staff
communication, catheter care, pain management, and use of physical restraints. The
physiological symptoms and behavior of delirium may include challenging behaviors, such as
altered mental status, agitation, restlessness, yelling, crying, and refusal of care (Mayo Clinic,
2018). Though these behaviors are common, they may be socially unacceptable in nursing
homes. These behaviors can interfere with residents’ activities of daily living, such bathing,
feeding, walking, toileting, and bed transfer.
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Daly, Bay, Levy, and Carnahan (2015) reported, “More than 80% of nursing home
residents with dementia exhibit one or more challenging behaviors … (including) agitation,
anger, depression, disrobing, eating abnormalities, hoarding, inappropriate sexual behavior,
irritability, paranoia, physical and verbal aggression, repetition, swearing, and withdrawal” (p.
182). Nurses can use behavioral modification techniques to ameliorate these behaviors; however,
these interventions can be time consuming (Weinberg, 2016). Staff may seek pharmacologic
methods to manage behaviors, but using antipsychotic medications inappropriately as a chemical
restraint is unethical and may cause adverse effects for elderly individuals (Department of Health
& Human Services [DHSS], 2014).
Current Nursing Home Practice
Nursing homes are often short staffed, and the staff work long hours with a high volume
of residents. Certified nursing assistants (CNAs) provide much of the care in nursing homes.
Routine CNA duties in nursing homes include providing activities of daily living, such as
feeding, bathing, toileting, transferring, and walking or exercising the residents (California
Department of Human Resources, 2017). When staffing is short, CNAs are assigned additional
residents, which increases their normal workload (Weinberg, 2016). These factors contribute to
the lack of time needed to implement behavioral management of residents with disruptive
behaviors. For these reasons, staff often pressure prescribers to order psychotropic medications
to control nursing home resident behaviors rather than using behavior modification to manage
these challenging behaviors (Tjia, Gurwitz, & Briesacher, 2012). Unfortunately, many residents
are given antipsychotic medications as an initial intervention to manage their challenging
behaviors without a proper interdisciplinary evaluation. Because of lack of training in behavioral
management and lack of knowledge in the use of psychotropic drug therapy, nursing staff may
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not be aware of the dangers of these medications in the older adult population and may not be
prepared to adequately care for residents with challenging behaviors (Daly et al., 2015). Staff
may seek pharmacological methods using psychotropic drugs to manage behaviors.
Available Knowledge
Despite the black box warning issued by the Food and Drug Administration (FDA),
nursing home residents continue to receive antipsychotic medication as initial intervention for
behavioral modification. Levin (2012) noted, the “FDA issued the black box warnings for
antipsychotics in response to approximately 15,000 elderly nursing home residents dying each
year from the off-label use of antipsychotic drugs” (p. 12). Prescribing these medications when
they are not medically indicated or in the patient’s best interest is the same as using a chemical
restraint and/or unnecessary drug.
In a literature review, Pakpoor and Agius (2014) found that neuroleptic malignant
syndrome, which includes fever, diaphoresis, rigidity, confusion, fluctuating consciousness,
fluctuating blood pressure, tachycardia, leukocytosis, and altered liver function tests, was a fatal
side effect for all antipsychotic medications. These side effects can lead to fatality, most
especially in an older adult because of age-related changes that affect kidney, liver, and
gastrointestinal function. The aging process can affect how the body metabolizes a drug from
ingestion to secretion through the kidneys, as well as specific action of the medications in fragile
older individuals (Braun & Frolik, 2000). Free radicals that are by-products of metabolism cause
oxidative damage to biomolecules as they damage the cellular membranes and impair
physiological functioning (Miller, 2018). Antipsychotic medication when used in the older adult
population needs frequent monitoring of side effects, vital signs, lab work, and possible dose
regulation due to the differences in body chemistry and drug metabolism in this population.
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A cohort study conducted by Huybrechts et al. (2012) included 83,959 Medicaid
recipients, age 65 or older, in 45 nursing homes in the United States, who initiated atypical
antipsychotic medication treatment after nursing home admission from 2001 to 2005.
Huybrechts et al. concluded that bacterial infections, myocardial infarctions, and hip fracture
rates were higher, and there was a risk of cerebrovascular events in those who initiated with
antipsychotic medications in nursing homes. Demonstrative conclusions were reached regarding
the adverse impact of antipsychotic medication, which can be fatal in the older adult population
(Huybrechts et al., 2012).
Alzheimer’s disease is a cognitive disorder that can manifest behavioral symptoms of
agitation or aggression (Lyketsos et al., 2011). These types of behaviors can be overwhelming to
residents, as well as to caregivers. According to the Alzheimer’s Association (2007), more than
50% of nursing home residents have some form of dementia or cognitive impairment, and many
residents with cognitive impairment manifest challenging behaviors, such as kicking,
restlessness, agitation, yelling, or refusing to receive care. Frequently, antipsychotic medications
are used as initial interventions, which may be why the use of antipsychotics has increased. It is
clear that many of these symptoms are physiological, are to be expected, and should not be
treated with antipsychotic medications.
Bonner et al. (2015) conducted a qualitative study of residents diagnosed with dementia
who received an antipsychotic medication. Bonner et al. conducted the research at 26 medium
and large facilities in five CMS regions. The researchers concluded that many of the prescribed
psychotropic drugs lacked evidence of supporting documentation for medication necessity or
proper diagnosis in the resident’s medical record (Bonner et al., 2015).
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It is critical for clinicians to recognize and uncover the underlying medical conditions of
behavioral disturbance or altered mental status for elderly residing in LTC facilities. Kiely et al.
(2013) studied delirium in 2,158 patients newly admitted to a post-acute facility and, using the
diagnostic algorithm of the Confusion Assessment Method, found approximately 16% of these
patients had delirium. In a 2009 study, High et al. concluded noted urinary tract infection at an
incidence of 0.12% cases per 1,000 resident-days. High et al. also found that pneumonia
develops among elderly nursing home residents at a rate of one episode per 1,000 days of care.
The elderly residing in LTC facilities are at greater risk for infection because of multiple
comorbidities that complicate in identifying such infections.
Basso, Siminioato, Dimonte, Scaglione, and Campagna (2018) conducted a retrospective
descriptive study using nursing home clinical records data from 2013 to 2016. Basso et al. found
that during that time period, 143 emergency department accesses occurred, with 55 (38.6%) for
medical problems in 48 residents. The most frequent reason for hospitalization was infection
(22): 18 respiratory infections, two urinary infections, and two with both respiratory and urinary
infection. On emergency department admission, prevalent signs and symptoms were desaturation
(13), dyspnea (10), and fever (nine). Basso et al. stressed the importance of explicit criteria to
promptly monitor changes in clinical conditions and the importance of educating professionals to
suspect an infection even with non-specific symptoms.
Ferguson et al. (2018) conducted a systemic review of 23 international studies to examine
the status of older adults living in LTC facilities and found variation in fluid intake intervention
and associated measurement of hydration outcomes. Across all of the reviewed evidence,
dehydration was identified as a leading threat to the health status of residents in LTC facilities
(Ferguson et al., 2018).
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Rationale
Dr. Jean Watson’s nursing theory of philosophy and science of caring promotes the health
of the nurse and the wellbeing of the patient (McEwen & Wills, 2014). Dr. Watson believes that
nurses are caring. She defines the nursing care profession as it combines with human and
scientific values to provide patient care. The theory assumption is that health professionals make
social, moral, and scientific contributions to humankind and that nurses’ caring ideal can affect
human development (McEwen & Wills, 2014). Dr. Watson believes that nursing care is a
transforming process for both the patient and the nurse. Philosophy and science of caring defines
the interpersonal process in the fulfillment of a patient’s need as the result of caring (McEwen &
Wills, 2014). For example, the facility or providers should find behavior modification
alternatives or examine the cause of the behaviors before prescribing antipsychotic medication.
Non-pharmacological interventions include redirection, encouraging residents to verbalize
feelings, music, art, massage, or providing other activities that residents enjoy.
Dr. Watson defined three of the four metaparadigm concepts (human being, health, and
nursing), and these concepts support the California Department of Public Health (CDPH) Skilled
Nursing Facility (SNF) Antipsychotic Toolkit (see Appendix A; McEwen & Wills, 2014). The
toolkit upholds the philosophy and science of caring. Examples of use of the toolkit include,
health care providers should examine the pathological causes of behavioral disturbance, and
residents presenting with behavioral and psychological symptoms of dementia should undergo
routine blood analysis and urinalysis. This can lead to both recognition of delirium and reduced
usage of antipsychotic medication (Wilson, Power, Owens, & Lawlor, 2019).
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Project Purpose
Specific Aims
Introduction of the CDPH SNF Antipsychotic Toolkit may reduce the rate of prescribing
antipsychotic medications compared to usual practice of antipsychotic use. Delirium and altered
mental status are associated with multiple complex underlying medical conditions and can be
difficult to recognize, particularly among elderly residing in LTC facilities. This DNP quality
improvement project involved the introduction of the use of the CDPH SNF Antipsychotic
Toolkit in the context of an educational training workshop designed to minimize negative effects
of age-related changes and modifiable risk factors of delirium. Three SNFs in Northern
California were invited to participate in the educational workshop training.
Goals
The quality improvement goals of this DNP project are:
1. Provide a mini course in behavioral modification interventions appropriate for the
older adult.
2. Introduce the CDPH SNF Antipsychotic Toolkit.
3. Encourage participating SNF staff to utilize the CDPH SNF Antipsychotic Toolkit.
4. Introduce the CDPH SNF Antipsychotic Toolkit into the facility policy for care.
Objectives
The objectives of this DNP project include:
1. Identify at least five SNFs in Northern California willing to coordinate educational
workshop training in reducing antipsychotics use, including criteria for delirium and
dementia by December 2018.
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2. Design a lesson plan and learning objectives workshop educational training
presentation by March 2019.
3. Design a tool to analyze effectiveness of educational workshop training (e.g., pre- and
post-survey workshop evaluation).
4. Present findings to interdisciplinary team (nursing home administrator [NHA],
director of nursing [DON] services, social worker, nursing staff, and rehabilitation
therapist) by July 2019.
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Section III. Methods
Context
The key members and stakeholders on this DNP project included the NHA, the DON,
social worker, nursing staff, health care provider, and rehabilitation therapist. Licensed nurses
should receive continuing education in taking care of the geriatric population, especially the side
effects of psychotropic medications and the guidelines in administration of psychotropic
medications. Educational training included identifying and preventing delirium, which can have
a positive effect on quality of care in nursing homes. The educational lecture included the
biologic theories of aging. Strengths, weaknesses, opportunities, and threat analysis (SWOT, see
Appendix B) and gap analysis (see Appendix C) of DNP project were identified.
Local Problem
A random review of public records in the Health Facilities Consumer Information System
under the CDPH noted a nursing home was cited for a FTAG 154 Informed of Health, Care, &
Treatments in March 2017 during the annual CDPH audit (see Appendix D). Based on the survey
audit, interviews, and record reviews, the facility failed to follow its policy and procedure to
ensure a physician-obtained informed consent for psychotherapeutic medication in a timely
manner prior to administering. This failure had a potential for a random sample resident
receiving psychotherapeutic medications without information needed to weigh benefits against
risk associated with psychotherapeutic medications, putting at risk for medication-associated
injury and harm (CDPH, 2017, p. 2). Using the CDPH SNF Antipsychotic Tool, along with
behavior modification techniques, is an ethical process that provides guidance in the appropriate
use of antipsychotics in older adults in nursing homes.
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The first step was contacting the NHA and the DON to collaborate for educational
workshop training through emails and phone calls. The NHA and the DON help to approve and
set up the workshop training in their facilities. Seven SNFs in Northern California were
contacted and three SNFs (Oakland, Hayward, and San Jose) agreed to the training. The training
was completed in December 2018.
In the second step, the DNP student integrated a literature review related to use of
antipsychotic medications in nursing homes. A comprehensive literature review to support these
recommendations was completed through Scopus, CINAHL, Joanna Briggs Institute EBP
Database, PubMed databases, and UpToDate. Search terms used were antipsychotic, adverse
effects, nursing home, dementia, Alzheimer, prevalence, assisted living facility, psychotropic, side
effects, chemical restraints, geriatric, and morale nursing home staffing. Publication dates for the
literature search were limited to 2000 to 2019. Limited information was found with initial date
limitation of five years, so the literature search was expanded to 20 years, then to less than 10
years, resulting in 166 articles. The critical appraisal of evidence (see Appendix E) noted
research from 2012 to 2018 relevant to the DNP project. The search was refined by limiting
acceptance of articles published in less than 10 years, English, reviews of the literature,
qualitative and quantitative research involving the geriatric population, LTC facilities, delirium,
and dementia. Eleven articles were selected applicable to the DNP project based on clinical
practice guidelines. These articles and systemic review significantly emphasized the effect of
antipsychotics medication in older adults, highlighted inappropriate use of psychoactive
medications in nursing homes, and emphasized the importance of identifying delirium. This
process of the DNP program was conducted from Fall 2016 to Spring 2019.
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In the third step, the DNP student created learning objectives for an educational training
workshop. The DNP student sought advice from two professors on the student’s committee at the
University of San Francisco. These two professors are family nurse practitioners with degrees of
Doctorate of Nursing Practice and Doctor of Philosophy in Nursing. It was identified that criteria
for dementia and delirium should be included in the workshop educational training.
Timeline
The Gantt chart presents the timeframe of DNP project (see Appendix F). The DNP
student interviewed SNF administrators in December 2018. In January 2019, the SNFs in Bay
Area, California were contacted to participate in the educational training program in managing
use of antipsychotics and in recognizing symptoms of delirium. The lesson plan for in-service
training was developed in February 2019. Itemized materials and tools for workshop training
were finalized in March 2019. Workshop training was completed June 3, 2019. Synthesis of data,
summarized recommendations, and outcome findings were concluded June 5, 2019.
Cost Summary and Benefits Analysis
LTC facilities are required to provide in-service training in managing dementia residents,
managing residents with behavioral disturbance, and the use of psychotropic medications. There
was no additional cost to the facilities for this DNP project, as this project can be used for the
mandatory in-service trainings.
Projected staffing and labor costs are presented as an estimated budget. Rates of
employees are presented as fair market value in Bay Area, California. In a 50-bed licensed
skilled nursing home, projected total staffing of three shifts includes 22 CNAs, 12 licensed
vocational nurses, six registered nurses (RNs), and one social worker. The projected annual cost
for a 1.5 hour training class is $1,591.50 (see Appendix G).
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Inappropriate use of antipsychotic medications in nursing homes can result in substantial
care deficiency or a resurvey during annual audit from the Department of Health. A declaration
from State Operations Manual, Survey and Enforcement Process for Skilled Nursing Facilities,
notes penalties can range from $1,000 to $10,000 per instance (CMS, 2018). Utilizing the CDPH
SNF Antipsychotic Toolkit is cost effective in avoiding citations and penalties. The check off list
of the toolkit is a guidance for ethical and evidence-based practice use of antipsychotics in
nursing homes.
Return on Investment
The return on investment in utilizing the CDPH SNF Antipsychotic Toolkit is improving
the quality of care of nursing home residents. The toolkit will help nursing home staff effectively
manage the clinical risk factors attributable to antipsychotic medication use in the elderly.
Nursing home staff will have the knowledge and resources to follow the guidelines step-by-step
in the use of antipsychotics medication in SNFs. The residents in LTC facilities will benefit from
using the off-label use of antipsychotics, which will improve the appropriate use of
antipsychotics in nursing home residents diagnosed with dementia, Alzheimer’s, and/or
cognitively impaired.
The return on investment of utilizing the CDPH SNF Antipsychotic Toolkit is avoidance
of imposition of civil money penalties from the CMS. A declaration from the State Operations
Manual, Survey and Enforcement Process for SNF, State Medicaid Agency may impose a civil
money penalty between $3,050 and $10,000 per day of immediate jeopardy (CMS, p. 7301.1,
2018).
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Intervention
Antipsychotic Use Survey Toolkit
The use of the CDPH SNF Antipsychotic Toolkit may reduce the use of antipsychotic
medications compared to the usual practice of prescribing antipsychotic medication (California
Association of Long-Term Care Medicine, 2012). The CDPH has created a process to monitor
inappropriate use of psychotropic medication in nursing homes. The CDPH SNF Antipsychotic
Toolkit checklists for administering antipsychotic medications includes:
1. Check to be sure behavioral symptoms are not due to:
a. An underlying medical condition (e.g., delirium, infection, pain, fluid or
electrolytes imbalance, polypharmacy side effects) that can be resolved or
improved.
b. Failure to recognize delirium. Clinicians often fail to recognize delirium, in some
reports, in more than 70% of cases (Francis & Young, 2014).
c. Environmental stress and psychological stressors (e.g., abuse, inadequate or
inappropriate staff response, unfamiliar care provider, change in daily routine).
d. Psychosis (e.g., auditory, visual, or other hallucinations; delusions) or the
behavioral symptoms present a danger to the resident or others.
2. Eliminate those non-evidence-based reasons:
a. Pertinent non-pharmacological interventions must be attempted, unless
contraindicated.
b. The prescribed medication represents the primary indication for use of the
antipsychotics.
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c. Monitor for effectiveness of prescribed antipsychotic, as well as the presence of
adverse consequences.
d. If the antipsychotic was initiated within the last year, the facility must attempt a
gradual dose reduction in two separate quarters.
e. Documentation present in the resident’s clinical record was reviewed monthly by
a consultant pharmacist.
f. Determine the prescribing physician provided material information necessary to
obtain informed consent and received consent from the resident.
Alternatives to Antipsychotics
Behavior modification as an alternative to the use of medications may include any of the
following (California Association of Long Term Care Medicine, 2012):
•

Review medications regimen. Older adults are at a higher risk of adverse drug events
due to physiological changes with advanced aged. Each medication should be
evaluated to identify side effects that can possibly cause alterations in mental status
that can manifest through behavioral disturbance (e.g., restlessness, irritability,
psychomotor agitation, and confusion).

•

Assess for pathological causes. Assess for underlying medical cause of altered mental
status. Order laboratory tests, such as comprehensive panel to examine for electrolyte
imbalance, dehydration, and infection.

•

Assess for depression. Depression can manifest through agitation and irritability;
physical and verbal aggression may be the primary manifestation of depression.

•

Review pain management. Pain is another example of physiological causes of
undesired behavior. Many nursing home residents cannot speak out for themselves
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when they experience pain, which can manifest through change of mood, such as
agitation, irritability, and restlessness.
Additional behavior modification recommendations from the Alzheimer’s Association
(2009) include:
•

Facilitate therapeutic communication. For example, use appropriate communication
aids or interpreter to meet resident’s communication needs. Use a comforting tone of
voice.

•

Assess and know the resident well. Learn to read his or her body language and get to
know the resident’s preference with care. Provide choices to resident to promote
dignity and independency.

•

Provide a routine and therapeutic environment. Allow sufficient time for the resident
to complete self-care.

•

Build a good rapport with the resident. Demonstrate a caring attitude, active
listening, and acknowledgement of resident’s feelings.

•

Avoid interrupting resident with cognitive impairment. They may lose their train of
thought. Speak slowly and calmly, and use short, simple words.

The projected implementation of the project was June 2019 (see Appendix F). The
development of the manuscript, prospectus development, and DNP project was completed in
August 2019. The project included educational workshop training, with in-services funded from
the educational training budget. The training was planned for approximately 45 minutes of
lecture and 15 minutes for open discussion. Nursing home facilities are mandated to provide
training in-services for all staff annually on care of dementia residents and managing behavioral
disturbance. The DNP project did not affect the training budget of the facility.
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The plan was to communicate to the NHA. The DON and the director of social services
work strictly on psychotropic medications. The DON coordinates the education for licensed
nurses and the interdisciplinary team members. A flyer was posted prior to the educational
training on site (see Appendix H). The work breakdown structure was used in communicating
with key personnel in the nursing skilled facilities (see Appendix I). Flyers provided to nursing
skilled facilities that participated in educational training.
Study of Intervention
The Department of Public Health (DPH) has created a process to monitor inappropriate
use of psychoactive medications to determine if clinical notes and care planning support the
prescription of these drugs. The CDPH SNF Antipsychotic Toolkit is an evidenced-based
assessment toolkit that allows for ethical care of the elderly within the regulations and
evidenced-based practice for use of antipsychotics. It is best practice to use the CDPH SNF
Antipsychotic Toolkit before prescribing and administering antipsychotic medications. The
toolkit emphasizes the importance of identifying signs and symptoms of delirium with care for
elderly in nursing homes. It is more ethical if nursing home facilities find behavior modification
alternatives or examine physiological changes that can alter mental cognition (urinary tract
infection, dehydration, and pulmonary tract infection) before prescribing and administering
antipsychotic medication (Alzheimer Association, 2009). The goal of behavioral management is
to provide health care providers with an understanding of factors that can contribute to cognitive
impairment in the older adult population, to identify and treat factors that are reversible, and to
suggest appropriate interventions to promote behavior management (Institute for Caregiver
Education, n.d). The purpose of this alternative to psychotropic medication is for each resident to
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attain and maintain his/her highest practicable wellbeing in an environment that prohibits the use
of restraints for discipline or convenience (DHSS, 2014).
Measures
Upon completion of the educational training of the DNP project, the health care provider
will be able to:
1. Identify at least three behavioral clinical presentations of delirium in elderly.
2. Identify behavioral side effects of common medications that could be misdiagnosed
as dementia or delirium.
3. Identify at least three possible outcomes from using antipsychotic medications in
elderly.
4. Identify possible non-pharmacological interventions in managing delirium or
dementia with behavioral disturbance.
5. Identify at least five criteria for psychotropic medication use in a nursing skilled
facility based on the CDPH SNF Antipsychotic Toolkit.
Analysis
The intended outcome of the project was to educate the nursing home staff, including
providers and nursing home management, that the CDPH SNF Antipsychotic Toolkit may reduce
the use of antipsychotic medications compared to usual practice on the use of antipsychotic
medication(s). The actual performance and potential gap analysis of the DNP project, including
SWOT analysis, were identified. Gannt chart and resources and materials (see Appendix J) are
itemized.
Evaluation and testing in education can be challenging for nursing home staff and in
developing a strong structured of learning and evaluation. A pre- and post-questionnaire should
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involve planning based on the staff’s knowledge of the purpose of the learning evaluation and
must correlate to test taker background knowledge. Pre- and post-questionnaires and workshop
evaluation were generated to evaluate effectiveness of workshop training and the DNP project
(see Appendix K).
Ethical Considerations
The University of San Francisco’s (USF, n.d.) core values are belief and commitment to
advancing social responsibility in achieving the university’s mission to create, communicate, and
apply knowledge to a world shared by all people. The DNP project was a quality improvement
project approved by the USF School of Nursing and Health Professions DNP committee. The
DNP project did not involve human subjects, and it did not require Institutional Review Board
(IRB) for the Protection of Human Subjects approval (see Appendix L). In 1987, to protect elders
and dependent residents from abuse and neglect in LTC facilities, federal legislation mandated
minimum health care requirements for nursing homes, including limitations on the use of
psychotropic medications. Any mandated reporter, within the scope of his or her employment,
has knowledge of an incident that reasonably appears or suspects to be physical abuse,
abandonment, abduction, isolation, financial abuse, chemical restraints, or neglect, shall report
immediately or as soon a practicably possible (California Department of Aging, (n.d).
The USF is committed to Jesuit values. The USF promotes a global perspective that
educates leaders who will fashion more humane care (USF, n.d). Jesuits draw on the rich
tradition of Ignatian spirituality and reflection and seek for the good of all humanity (Jesuits,
n.d). This DNP project promotes Jesuits values and clinical relevance of the CDPH SNF
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Antipsychotic Toolkit in geriatric populations. Jesuits values are well-suited with the ethical
practice of health care using evidence-based practice.
Results
Qualitative Findings
The plan was to implement the workshop training in three SNFs. Only one nursing home
succeeded in receiving the workshop training. The three NHAs were the direct contacts for the
DNP project.
The first SNF is licensed with less than a 100-bed capacity in Oakland, California. The
NHA cancelled the workshop training a week before the scheduled date. It was cancelled
because the facility was currently experiencing widespread concern related to care that could
potentially harm residents. The NHA stated it may take some time to correct the current problem,
but the NHA remarked as to the importance of utilizing the SNF Antipsychotic Toolkit, since the
use of psychotropic medications is highly regulated in the SNF. The NHA stated SNFs are
experiencing deficiency ratings due to inappropriate use of antipsychotics and lack of
educational training in managing residents with diagnosis of dementia.
The second SNF is one of the largest sub-acute centers in Northern California. The
training at this facility was cancelled on the week of the scheduled date because the Department
of Health was there for the annual audit. The NHA corresponded that it was important to use the
SNF Antipsychotic Toolkit to decrease the use of psychotropic medications in elderly
populations. The NHA emphasized the importance of educating the nursing home staff with nonpharmacological interventions and periodic workshop training in managing residents diagnosed
with dementia.
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The third SNF has a less than 50-bed licensed capacity. The workshop educational
training was held as planned. The NHA has more than five years of experience in SNFs. The
NHA specified that staff would be able to do better in understanding psychotropic regulations if
staff utilized the CPDH SNF Antipsychotic Toolkit. The social worker at this facility has a
Master’s in Social Work, with more than five years of experience. The social worker would like
to learn more about the side effects of psychotropic medications. The director of utilization
rehabilitation (DUR) therapy corresponded utilizing the CDPH SNF Antipsychotic Toolkit is
imperative.
The training attendees (NHA, social worker, DUR, and RN) are interested in attending a
follow-up, more advanced workshop on this same subject. The attendees recommended that the
workshop be offered to other colleagues. They also stated that the training was applicable to their
job and that the educational training will more likely change their practice in relation to
psychotropic medications.
Quantitative Findings
One of the three SNFs invited to participate in the training succeeded in presenting the
educational workshop training. There were seven participants in the educational workshop
training. Two participants were excluded in the quantitative analysis because they did not
provide direct patient care and one nursing participant did not complete the surveys. Five
participants were included in the analysis. See Appendix M for the full results.
Pre-training survey. Although the staff have experience working in nursing homes, the
findings suggest that staff need training in the use of antipsychotic medications in LTC facilities.
Most participants felt neutral or somewhat comfortable in the use of antipsychotic medications.
Pre training, the staff were not comfortable with answering the CMS guidelines with step-by-step
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instructions in an effort to reduce use of unnecessary antipsychotic use. The staff were not at all
comfortable in identifying signs and symptoms of delirium that can be mistaken as dementia in
nursing homes. These finding suggest that the staff need training in providing nonpharmacological interventions prior to use of psychotropic medications. Table 1 displays the full
results from the pre-training questionnaire
Table 1
Pre-Training Survey
Question
How comfortable are you with Department of Health Surveyors during
annual survey in answering questions in relation of using antipsychotic
medication with residents?
How comfortable are you in identifying signs and symptoms of
delirium?
How comfortable are you in providing non-pharmacological
interventions with residents manifesting behavioral disturbance
How comfortable are you in identifying possible adverse effects of
antipsychotic with in older adults?

Mean

SD

3.60

1.14

3.80

0.84

3.80

0.84

3.60

0.55

Post-survey. Post-training, the participants felt more comfortable, on average, with the
use of antipsychotic medications and in identifying the signs and symptoms of delirium.
Table 2
Post-Training Survey
Question
How comfortable are you with Department of Health Surveyors during
annual survey in answering questions in relation of using antipsychotic
medication with residents?
How comfortable are you in identifying signs and symptoms of
delirium?
How comfortable are you in providing non-pharmacological
interventions with residents manifesting behavioral disturbance
How comfortable are you in identifying possible adverse effects of
antipsychotic with in older adults?

Mean

SD

4.60

0.55

4.60

0.55

4.60

0.55

5.00

0.00
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Workshop evaluation. Post-training, the participants feedback on workshop training that
it is relevant and applicable to their practice.
Table 3
Workshop Evaluation
Question
The workshop was applicable to my job.
I will recommend this workshop to my colleagues.
The educational training will more likely to change my practice.
I would be interested in attending a follow-up, more advanced
workshop on this same subject.

Mean
5.00
5.00
4.80

SD
0.00
0.00
0.45

5.00

0.00

Post-implementation. The DNP student promoted the utilization of the CDPH
Antipsychotic Toolkit into practice. NHAs are considering enforcement in utilization of the
CDPH Antipsychotic Toolkit into practice. The NHA and the DNP student (a former DON) are
former colleagues in a 140-bed SNF in Northern California. The NHA and the DNP student
utilized the CDPH Antipsychotic Toolkit in that facility, with a remarkable decrease in use of
psychotropic medications. The NHA expressed that nursing staff, including the interdisciplinary
team at the current facility, need to attend periodic workshop training to understand dementia,
delirium, and the purpose of CDPH Antipsychotic Toolkit.
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Section IV: Discussion
Summary
Goal 1
Goal 1 was to implement the workshop training into at least three SNFs. The goal was
successful with one SNF. The DNP student contacted at least five SNFs in Bay Area, California.
Three SNFs agreed to participate in the educational workshop training. Due to facility
circumstances, two SNF trainings did not materialize as planned. The DNP student was able to
implement the training at one SNF. The DNP project educational workshop training was
implemented at a local SNF in Northern, California. The SNF is a less than 50-bed licensed
facility located in Eastbay, California. This SNF was closed down by the DPH due to
substandard care and negligence. It is now under new ownership and management. The SNF
received the license to operate again in the first quarter of 2019.
Goal 2
Goal 2 was for the DNP student to provide educational training on delirium and
dementia. The DNP student was able to provide introduction of clinical presentation of delirium
in the elderly. The staff was able to identify behavioral side effects of common medications that
could be misdiagnosed as dementia or delirium. The DNP student was able to discuss possible
outcomes from using antipsychotic medications in elderly.
Goal 3
Goal 3 was to provide a behavioral modification intervention workshop training. The
DNP student discussed possible non-pharmacological interventions in managing delirium or
dementia with behavioral disturbance. The DNP student remarked that nursing home staff need
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periodic training of non-pharmacological interventions in managing delirium, dementia, and
residents with behavioral disturbance.
Goal 4
Goal 4 was to introduce the CDPH SNF Antipsychotic Toolkit. The DNP student was
able to discuss the criteria and step-by-step utilization of the CDPH SNF Antipsychotic Toolkit.
The DNP student emphasized the importance of utilization of the CDPH SNF Antipsychotic
Toolkit to reduce the inappropriate use of psychotropic medication in current practice.
Final Goal
The final goal of the DNP project was to have the participating SNF utilize the CDPH
SNF Antipsychotic Toolkit into practice. The DNP student discussed this with the NHA postimplementation in utilizing the CDPH SNF Antipsychotic Toolkit. The NHA recommended that
periodic workshop training is important to enforce the use of the toolkit.
Interpretation
Despite studies that support the danger of psychotropic drug use in older adult
populations and an FDA black box warning about the serious side effects, psychotropic drugs are
still commonly used in nursing homes instead of finding alternatives to managing residents’
behavioral and emotional states. Elder abuse and neglect is one of the complex and serious
consequences that affects this vulnerable population (Miller, 2018). Inappropriate use of
antipsychotic drugs is a form of elder abuse, with chemical restraints imposed for purposes of
convenience, and is not required to treat the resident’s medical symptoms. Implementing the
CDPH SNF Antipsychotic Toolkit will increase awareness of guidelines on the use of
antipsychotics and in recognizing signs and symptoms of delirium with the elderly population
residing in LTC facilities. It is critical for nursing home staff to identify signs and symptoms of
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delirium and to communicate identified symptoms and behavior change(s) to the medical
provider to correct modifiable risk factors of delirium (dehydration, infection, environmental risk
factors, and medications).
Limitations
There were limitations identified in implementing the quality improvement project. Due
to the educational budget, the maximum time allotted for the DNP project workshop training was
45 minutes at the nursing home site. The learning objectives of the educational workshop
training was for at least two hours that would include discussions. The goal of the DNP
improvement project was to increase awareness of guidelines using antipsychotics (goal is to
decrease use of antipsychotics) in the elderly in LTC facilities. Evaluating the effectiveness of
DNP project in actual performance (use of antipsychotic medications) needs at least three
quarters of the year for data collection. Use of antipsychotic medications may also depend on
risk factors and comorbidity of residents.
Conclusions
Nursing home staff should have increased awareness in clinical manifestations of
delirium (psychomotor agitation, sleep-wake reversals, irritability, anxiety, emotional lability,
and hypersensitivity to lights and sounds), because elderly residents with delirium often do not
look sick separately from their behavioral changes (Francis & Young, 2014). Nursing care should
focus on minimizing negative effects of age-related changes (e.g., sensory and cognition
impairment and chronic health conditions) and modifiable risk factors of delirium (dehydration,
infection, environmental risk factors, medications, and restraints). The CDPH SNF Antipsychotic
Toolkit promotes older adult wellness in physical and psychosocial function. Nursing home
residents have the right to be free from involuntary seclusion and free from any physical or
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chemical restraints imposed for purposes of convenience, which are not required to treat the
resident’s medical symptoms (Braun & Frolik, 2000). Antipsychotic medications must be used
with caution because of the serious side effects (e.g., cardiac arrest, abnormal involuntary muscle
movement, altered liver function, and neuroleptic syndrome) that can lead to serious health
issues. The CDPH SNF Antipsychotic Toolkit emphasizes the importance of identifying signs
and symptoms of delirium with care for elderly in nursing homes. The CDPH SNF Antipsychotic
Toolkit is an evidenced-based assessment toolkit that allows for ethical care of the elderly within
the regulations and evidence-based practice for use of antipsychotics.
Disclosure
The DNP project was a quality improvement development approved by the DNP
committee chair in School of Nursing and Health Professions at USF. The DNP project did not
involve human participant subjects and did not require IRB approval. The DNP project protected
the privacy of participants and the facility involved.
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Appendix B
SWOT Analysis
Strengths
•
•
•
•
•

It provides an educational training for health care providers and nursing home
management to learn and utilize the CDPH SNF Antipsychotic Toolkit.
Many nursing home staff lack training in following guidelines of antipsychotics in SNF.
Increase knowledge on residents’ rights in nursing homes.
Increase knowledge in physiological effect on antipsychotic medication in older adults.
Increase awareness in signs and symptoms of delirium.

Weaknesses
•
•

NPs, MDs, Psychologist, and Psychiatrist may not attend the educational training and
utilize CDPH SNF Antipsychotic Toolkit.
Nurses can use behavioral modification techniques to modify these behaviors; however,
these interventions can be time consuming.

Opportunities
•
•
•
•

Receive training on behavioral modifications of residents with a diagnosis of dementia or
cognitive problems including behavioral symptoms.
The CDPH SNF Antipsychotic Toolkit can be included in the policy and procedure of the
facility in using antipsychotics medications.
The nursing staff will have increased knowledge in clinical presentations of delirium in
elderly.
The facility must try non-pharmacological interventions in managing behavioral
symptom(s).

Threats
•
•
•

It will cost money/budget to pay the nursing staff for the educational training.
Nursing homes are often short staffed and offer low pay, with long work hours and high
work volume.
Because of the short staffing and longer work hours, caregivers do not have enough time
to complete the policy and procedures required to document or provide safe and quality
care, most especially maintaining dignity of residents (Weinberg, 2016).
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Appendix C
Gap Analysis
Actual performance
•

Despite studies that support the danger of psychotropic drug use in elderly
populations and an FDA black box warning about the serious side effects,
psychotropic drugs are commonly used in nursing homes instead of finding
alternatives to managing residents’ behavioral and emotional states.

•

Due to lack of training in behavioral management and knowledge in use of
psychotropic drug therapy, nursing staff may not be aware of the dangers of these
medications in elderly populations and may not be prepared to adequately care for
residents with challenging behaviors (Daly et al., 2015).

Potential
•

The utility of CDPH SNF Antipsychotic Toolkit may reduce the use of antipsychotics
compared to usual practice in the use of antipsychotic medications.

•

Nursing staff in nursing homes, including nursing assistants, will have increased
awareness in signs and symptoms of delirium.

•

Before prescribing a drug regimen to a resident, most especially antipsychotics, a
comprehensive assessment and referrals to other disciplines (psychiatrist,
psychologist, or social services) should be considered and to be aware of the possible
adverse effects.

•

To assess and discuss possible adverse effects of the drug regimen, such as
monitoring of lab works, abnormal involuntary body movements, and
electrocardiogram to monitor heart rhythm.
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Appendix E
Critical Appraisal of Evidence
Citation

Conceptual
Framework

Design/
Method

Huybrechts
et al., 2012

None

Quantitative
study,
comparative
safety of
antipsychotic
medications in
nursing home
residents.

Bonner et
al., 2015

None

Qualitative
and
descriptive,
rationales of
providers and
family
members for
use of
antipsychotics
in nursing
home.

Sample
Setting

Variables
Studied and
Their
Definitions
Nursing homes
Reviewed data
in 45 U.S.
for an
states.
association
between
83,959 Medicaid typical and
eligible
atypical
residents ≥ 65
antipsychotics
who initiated
and the main
antipsychotic
side effects.
treatment
following
nursing home
admission in
2001-2005.
26 medium and
Individuals
large facilities in diagnosed
five CMS
with dementia
regions.
who received
an
antipsychotic
medication.

Measurement

Data Analysis

Findings

Hospitalization
for MI, CVA,
bacterial
infections &
hip fracture
within 180
days of
treatment
initiation.

Propensity
score-adjusted
proportional
hazards models
were used.

Bacterial infections,
myocardial infarction, and
hip fracture rates and risks
of cerebrovascular events
demonstrated significant
risk.

Medical record
abstraction,
interviews with
prescribers,
staff, family.

Coding scheme
and coded
reasons for
antipsychotic
use.

Many of the prescribed
psychotropic drugs lacked
evidence of supporting
documentation for
medication necessity or
proper diagnosis in the
resident medical record.
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Pakpoor &
Agius,
2014

None

Levin,
2012

None

Azermai et
al., 2014

None

Literature
review,
adverse side
effects
associated
with
antipsychotics
as related to
their efficacy.
Literature
review, lifting
the fog: The
problem of
antipsychotic
drug use in
nursing
facilities.

Review the data
for an
association
between typical
and atypical
antipsychotics.

Address
complex
medical issues
of treating
elderly in
nursing homes
with
antipsychotics
and summarize
federal
legislation in
nursing homes.
Mixed-method On selected
study
nursing home
involving an
residents in
expert
Belgian nursing
meeting, a
homes to
survey using
generate casestructured
specific
questionnaires information.
distributed to
responsible
nurses and
treating
general
practitioners.

50

EPS,
metabolic
effects, tardive
dyskinesia –
typical, weight
gain, QTc.

Not applicable.

Reported
subcategories
side effect of
typical, atypical
antipsychotics.

The study concluded
neuroleptic malignant
syndrome is a fatal side
effect for all antipsychotic
medications.

Reviewed data Not applicable.
on excessive
dependence on
antipsychotic
treatment for
dementiarelated
behavioral
problems.

Review of
legislative,
judicial, and
policy
consideration.

Food and Drug
Administration issued the
black box warnings for
antipsychotics in response
to 15,000 nursing home
residents dying each year
from the off-label use of
antipsychotic drugs.

Antipsychotic
users (n =
113) had a
mean age of
81 years
(range 57–97);
62% were
female and
81% had
moderate to
severe
cognitive
impairment.

Not stated.

Nurses and general
practitioners share a very
low willingness and high
barriers to antipsychotic
discontinuation.

Not stated.
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Basso et
al., 2018

Kiely et al.,
2013

None

None

Retrospective
study using
nursing home
clinical
records from
2013-2016.

Delirium
status was
categorized
into four
groups: full,
two or more
symptoms,
one symptom,
and no
delirium.
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Nursing home
residents
transferred to
ED for
respiratory,
cardiovascular,
and neurological
problem and
symptoms of
infections.

Not available

2,158 subjects
were recruited
from seven
Boston-area
SNFs
specialized in
post-acute care.

CAM –
defined
delirium at
admission to
the post-acute
facility.

Not stated.

Assessment
instrument
included MiniMental Status
Exam,
Delirium
Interview,
Memorial
Delirium
Assessment
Scale, and
CAM.

In 4 years (20132016), 143 ED
access occurred,
55 (38%) for
medical
problems in 48
residents.

Descriptive
statistics were
calculated and
chi-square
analyses and an
analysis-ofvariance were
used to examine
delirium
characteristics
by group.

Most frequent reason for
ED: infection (22)
respiratory (18), urinary (2)
or both (2).
The week before ED 1/3 of
residents were
asymptomatic.
ED admission prevalent
signs: desaturation,
dyspnea, fever.
Among 2,158 subjects,
16% CAM-defined
delirium at admission to
post-acute, 13% had two or
more symptoms of
delirium, 40% had one
delirium symptom, 32%
had no delirium symptoms.
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Gantt Chart
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Appendix G
Cost Benefit and Analysis
Project Cost of In-Service in 50-Bed Facility
Fair Market Rate
Nursing Homes In
Bay Area, California
Per Hour

Trainees
Certified Nursing Assistant
(CNA)
Licensed Vocational Nurse
(LVN)

Projected
Staffing

Total Cost
Annually

$18.00 x 1.5 hours

22 CNAs

$594.00

$30.00 x 1.5 hours

12 LVNs

$540.00

Registered Nurse (RN)

$45.00 x 1.5 hours

6 RNs

$405.00

Social Worker (SW)

$35.00 x 1.5 hours

1 SW

$52.50

PROJECTED TOTAL COST

$1,591.50

HAZARDS OF ANTIPSYCHOTICS IN NURSING HOMES
Appendix H
Flyer
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Work Breakdown System / Communication Plan
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Appendix J
Resources and Materials
Print Materials
•

California Department of Health L&C SNF Antipsychotic Use Survey Toolkit

•

Power Point presentation on Hazards of Antipsychotics in Nursing Homes

•

Pre- and post-questionnaires

•

Workshop Evaluation

•

Agenda

•

Flyers

Online Access Resources
•

California Department of Health L&C SNF Antipsychotic Use Survey Toolkit:
https://www.caltcm.org/assets/documents/forms/cdph_lc_antipsychotic_survey_tool_
07_11_12.pdf

•

Department of Health & Human Services. Centers for Medicare & Medicaid
Services. CMS Manual System: https://www.cms.gov/Regulations-andGuidance/Guidance/Transmittals/downloads/R22SOMA.pdf

•

Long-Term Care Community Coalition:
http://www.ltccc.org/publications/documents/ltccc-antipsychotic-drugs-oversightftags-mar2013.pdf
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Appendix K
Pre- and Post-Questionnaire and Workshop Evaluation
Pre-Questionnaire
Your response will provide the best possible outcome of the educational training.
What is your job title?
 MD  NP
 RN

 LVN

 Others_____

How many years of experience in your profession?
 <1 year
 2-3 years
 4-5 years

 > 5 years

Did you ever use or know about the SNF Antipsychotic Toolkit prior to this training?
 YES
 NO
1. How comfortable are you in identifying or recognizing signs and symptoms of delirium?

Least Comfortable







1

2

3


4


5

Very Comfortable

2. How comfortable are you what to examine to a resident before administering or prescribing
antipsychotic medication in nursing skilled facility within the regulation?

Highly Comfortable











1

2

3

4

5

Very Comfortable

3. How comfortable are you in providing non-pharmacological interventions with resident manifesting
behavioral disturbance?

Highly Comfortable











1

2

3

4

5

Very Comfortable

4. How comfortable are you with Department of Health Surveyors during annual survey in answering
questions in relation of using antipsychotic medication with residents?

Highly Comfortable











1

2

3

4

5

Very Comfortable

5. How comfortable are you in identifying possible adverse effects of antipsychotic medication with in
older adults?
Highly Comfortable











1

2

3

4

5

Very Comfortable

6. How comfortable are you when verifying or prescribing antipsychotic medication in nursing skilled
facility within the regulation?

Least Comfortable







1

2

3


4


5

Very Comfortable
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Post-Questionnaire
Your response will provide the best possible outcome of the educational training.

1. How comfortable are you in identifying signs and symptoms of delirium?

Least Comfortable







1

2

3


4


5

Very Comfortable

2. How comfortable are you what to rule out before administering or prescribing antipsychotic
medication in nursing skilled facility within the regulation?

Least Comfortable











1

2

3

4

5

Very Comfortable

3. How comfortable are you in providing non-pharmacological interventions with resident manifesting
behavioral disturbance?

Least Comfortable







1

2

3


4


5

Very Comfortable

4. How comfortable are you with Department of Health Surveyors during annual survey in answering
questions in relation of using antipsychotic medication with residents?

Least Comfortable







1

2

3


4


5

Very Comfortable

5. How comfortable are you in identifying possible adverse effects of antipsychotic medication with in
older adults?
Least Comfortable











1

2

3

4

5

Very Comfortable

6. How comfortable are you when verifying or prescribing antipsychotic medication in nursing skilled
facility within the regulation?

Least Comfortable







1

2

3


4


5

Very Comfortable
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Workshop Evaluation Form
Training Location: __________________________________
Date: _______________________
Job Title: ____________________
Years in present position? <1

1-3

3-5

+5

INSTRUCTIONS:
Please
Strongly
agree
1

2

3

Strongly
disagree
4
5

2. The workshop was applicable to my job

1

2

3

4

5

3. I will recommend this workshop to my colleagues

1

2

3

4

5

4. The program was well paced within the allotted time

1

2

3

4

5

5. The educational training will more likely change my practice

1

2

3

4

5

6. The material was presented in an organized manner

1

2

3

4

5

7. The instructor was knowledgeable on the topic

1

2

3

4

5

8. I would be interested in attending a follow-up, more
advanced workshop on this same subject

1

2

3

4

5

9. I would be interested in attending a follow-up, more
advanced workshop on this same subject

1

2

3

4

5

1. I was well informed about the objectives of this workshop

10. Given the topic, was this workshop:

❑ a. Too short

❑ b. Right length ❑ c. Too long

11. In your opinion, was this workshop:

❑ a. Introductory ❑ b. Intermediate ❑ c. Advanced

12. What did you most appreciate/enjoy/think was best about the course? Any suggestions for
improvement?

14. What is the least valuable about this workshop?

15. What is the most valuable about this workshop?
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16. I would be able to do my work better if I knew more about>

17. Please describe the top two topics you would like to learn more about in the next 12 months:
Topic
1:_____________________________________________________________________________

Topic
2:_____________________________________________________________________________

Please return this form to the instructor or organizer at the end of the workshop. Thank you.
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Appendix L
DNP Statement of Non-Research Determination Form

Student Name: Nino D. Flores, RN MSN
Title of Project: Hazards of Antipsychotic in Nursing Homes
Brief Description of Project: Introduction of the California Department of Public
Health’s Skilled Nursing Facility (CDPH SNF) Antipsychotic Toolkit may reduce the use
and or prescribing of antipsychotic medications compared to usual practice of
antipsychotic use. Delirium and altered in mental status are associated with multiple
complex underlying medical conditions and they can be difficult to recognize,
particularly among elderly residing in long term care facilities.
A) Aim Statement: The use of the CDPH SNF Antipsychotic Toolkit allows for
ethical and evidence-based care of the elderly within the regulations and best practice
for use of antipsychotics.
B) Description of Intervention: Quality improvement project is to provide: a) an
educational training on delirium and dementia, b) behavioral modifications, and c)
introducing CDPH SNF Antipsychotic Toolkit to local nursing homes in Northern,
California.
C) How will this intervention change practice? Increase awareness and knowledge
in regulations use of CDPH SNF Antipsychotic Toolkit may decrease use of
antipsychotics in residents of nursing homes and to increase awareness signs and
symptoms of delirium.
D) Outcome measurements: Pre and Post survey questionnaires, and workshop
evaluation will be administered to healthcare participants.

To qualify as an Evidence-based Change in Practice Project, rather than a Research Project, the
criteria outlined in federal guidelines will be used:
(http://answers.hhs.gov/ohrp/categories/1569)

☐ x This project meets the guidelines for an Evidence-based Change in Practice Project as
outlined in the Project Checklist (attached). Student may proceed with implementation.

☐This project involves research with human subjects and must be submitted for IRB approval
before project activity can commence
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Comments:
EVIDENCE-BASED CHANGE OF PRACTICE PROJECT CHECKLIST *

Instructions: Answer YES or NO to each of the following statements:
Project Title: Hazards of Antipsychotics in Nursing Home
The aim of the project is to improve the process or delivery of care with
established/ accepted standards, or to implement evidence-based change. There is
no intention of using the data for research purposes.
The specific aim is to improve performance on a specific service or program and is
a part of usual care. ALL participants will receive standard of care.
The project is NOT designed to follow a research design, e.g., hypothesis testing
or group comparison, randomization, control groups, prospective comparison
groups, cross-sectional, case control). The project does NOT follow a protocol that
overrides clinical decision-making.
The project involves implementation of established and tested quality standards
and/or systematic monitoring, assessment or evaluation of the organization to
ensure that existing quality standards are being met. The project does NOT
develop paradigms or untested methods or new untested standards.
The project involves implementation of care practices and interventions that are
consensus-based or evidence-based. The project does NOT seek to test an
intervention that is beyond current science and experience.
The project is conducted by staff where the project will take place and involves
staff who are working at an agency that has an agreement with USF SONHP.
The project has NO funding from federal agencies or research-focused
organizations and is not receiving funding for implementation research.
The agency or clinical practice unit agrees that this is a project that will be
implemented to improve the process or delivery of care, i.e., not a personal
research project that is dependent upon the voluntary participation of colleagues,
students and/ or patients.
If there is an intent to, or possibility of publishing your work, you and supervising
faculty and the agency oversight committee are comfortable with the following
statement in your methods section: “This project was undertaken as an Evidencebased change of practice project at X hospital or agency and as such was not
formally supervised by the Institutional Review Board.”

YES

NO

Yes

Yes
Yes

Yes

Yes

Yes
Yes
Yes

Yes

ANSWER KEY: If the answer to ALL of these items is yes, the project can be considered an
Evidence-based activity that does NOT meet the definition of research. IRB review is not
required. Keep a copy of this checklist in your files. If the answer to ANY of these questions
is NO, you must submit for IRB approval.
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*Adapted with permission of Elizabeth L. Hohmann, MD, Director and Chair, Partners Human
Research Committee, Partners Health System, Boston, MA.

STUDENT NAME (Please print):
Nino Dantes Flores, RN MSN
________________________________________________________________________

Signature of Student:
______________________________________________________DATE____________

SUPERVISING FACULTY MEMBER (CHAIR) NAME (Please print):
Dr. Jo Loomis, DNP, FNP-C, CHSE, CLC, ANLC, NCMP, CNL
________________________________________________________________________

Signature of Supervising Faculty Member (Chair):
______________________________________________________DATE____________
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